Glaxo Smith Kline Pakistan Limited informed Pakistan Stock Exchange that Mr. Simon Forster has been appointed as Non-Executive Director of the company with effect from September 28, 2022 in place of MR. Mark Robert Dawson.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
100.4 PKR | +2.43% | +9.73% | +20.98% |
1st Jan change | Capi. | |
---|---|---|
+20.98% | 115M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- GLAXO Stock
- News GlaxoSmithKline Pakistan Limited
- Glaxosmithkline Pakistan Limited Appoints Simon Forster as Director